Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Actinium Pharmaceuticals, Inc. (ATNM) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Actinium Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1388320.
Total stock buying since 2016: $170,126.
Total stock sales since 2016: $1,894,313.
Total stock option exercises since 2016: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2018 | 79,730 | $38,793 | 0 | $0 | 0 | $0 |
| 2017 | 59,333 | $50,880 | 0 | $0 | 0 | $0 |
| 2016 | 45,500 | $80,453 | 992,826 | $1,894,313 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2018-12 | 20,000 | $8,720 | 0 | $0 | 0 | $0 |
| 2018-11 | 10,000 | $4,500 | 0 | $0 | 0 | $0 |
| 2018-07 | 10,000 | $7,900 | 0 | $0 | 0 | $0 |
| 2018-06 | 12,000 | $6,000 | 0 | $0 | 0 | $0 |
| 2018-04 | 5,000 | $1,900 | 0 | $0 | 0 | $0 |
| 2018-02 | 22,730 | $9,773 | 0 | $0 | 0 | $0 |
| 2017-08 | 43,333 | $32,499 | 0 | $0 | 0 | $0 |
| 2017-06 | 16,000 | $18,381 | 0 | $0 | 0 | $0 |
| 2016-12 | 10,000 | $9,300 | 0 | $0 | 0 | $0 |
| 2016-08 | 0 | $0 | 252,395 | $454,143 | 0 | $0 |
| 2016-07 | 0 | $0 | 174,880 | $319,699 | 0 | $0 |
| 2016-06 | 0 | $0 | 110,673 | $217,593 | 0 | $0 |
| 2016-05 | 0 | $0 | 205,804 | $396,061 | 0 | $0 |
| 2016-04 | 35,500 | $71,153 | 249,074 | $506,817 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-12-10 | O'loughlin Steve (Principal Financial Officer) | Buy | 10,000 | .43 | 4,350 |
| 2018-12-10 | Seth Sandesh (Chairman & CEO) | Buy | 10,000 | .44 | 4,370 |
| 2018-11-19 | Ludwig Dale L. (Chief Scientific Officer) | Buy | 10,000 | .45 | 4,500 |
| 2018-07-17 | Seth Sandesh (CEO) | Buy | 10,000 | .79 | 7,900 |
| 2018-06-15 | O'loughlin Steve (Principal Financial Officer) | Buy | 12,000 | .50 | 6,000 |
| 2018-04-19 | Seth Sandesh (Chairman & CEO) | Buy | 5,000 | .38 | 1,900 |
| 2018-02-28 | Shetty Ajit | Buy | 22,730 | .43 | 9,773 |
| 2017-08-02 | Ray Nitya G. (Executive Vice President) | Buy | 10,000 | .75 | 7,500 |
| 2017-08-02 | Seth Sandesh (Chairman & CEO) | Buy | 33,333 | .75 | 24,999 |
| 2017-06-15 | Berger Mark Stanley (Chief Medical Officer) | Buy | 5,000 | 1.11 | 5,550 |
| 2017-06-15 | O'loughlin Steve (Principal Financial Officer) | Buy | 3,500 | 1.17 | 4,094 |
| 2017-06-15 | Seth Sandesh (Chairman and CEO) | Buy | 7,500 | 1.17 | 8,737 |
| 2016-12-30 | Seth Sandesh (Executive Chairman) | Buy | 5,000 | .88 | 4,400 |
| 2016-12-12 | Seth Sandesh (Executive Chairman) | Buy | 5,000 | .98 | 4,900 |
| 2016-08-31 | Memorial Sloan-kettering Cancer Center | Sale | 136,853 | 1.83 | 250,851 |
| 2016-08-30 | Memorial Sloan-kettering Cancer Center | Sale | 56,074 | 1.81 | 101,493 |
| 2016-08-29 | Memorial Sloan-kettering Cancer Center | Sale | 25,000 | 1.72 | 42,875 |
| 2016-08-26 | Memorial Sloan-kettering Cancer Center | Sale | 25,000 | 1.71 | 42,625 |
| 2016-08-16 | Memorial Sloan-kettering Cancer Center | Sale | 5,029 | 1.72 | 8,664 |
| 2016-08-15 | Memorial Sloan-kettering Cancer Center | Sale | 4,439 | 1.72 | 7,635 |
| 2016-07-12 | Memorial Sloan-kettering Cancer Center | Sale | 3,100 | 1.80 | 5,595 |
| 2016-07-11 | Memorial Sloan-kettering Cancer Center | Sale | 800 | 1.80 | 1,440 |
| 2016-07-08 | Memorial Sloan-kettering Cancer Center | Sale | 21,190 | 1.80 | 38,142 |
| 2016-07-06 | Memorial Sloan-kettering Cancer Center | Sale | 10,500 | 1.80 | 18,900 |
| 2016-07-05 | Memorial Sloan-kettering Cancer Center | Sale | 10,340 | 1.82 | 18,870 |
| 2016-07-01 | Memorial Sloan-kettering Cancer Center | Sale | 128,950 | 1.84 | 236,752 |
| 2016-06-30 | Memorial Sloan-kettering Cancer Center | Sale | 19,150 | 1.81 | 34,604 |
| 2016-06-15 | Memorial Sloan-kettering Cancer Center | Sale | 33,619 | 1.90 | 63,876 |
| 2016-06-02 | Memorial Sloan-kettering Cancer Center | Sale | 17,790 | 2.01 | 35,757 |
| 2016-06-01 | Memorial Sloan-kettering Cancer Center | Sale | 40,114 | 2.08 | 83,356 |
| 2016-05-31 | Memorial Sloan-kettering Cancer Center | Sale | 129,336 | 1.93 | 249,359 |
| 2016-05-26 | Memorial Sloan-kettering Cancer Center | Sale | 40,068 | 1.93 | 77,251 |
| 2016-05-25 | Memorial Sloan-kettering Cancer Center | Sale | 36,400 | 1.91 | 69,451 |
| 2016-04-26 | Memorial Sloan-kettering Cancer Center | Sale | 6,500 | 1.96 | 12,740 |
| 2016-04-25 | Memorial Sloan-kettering Cancer Center | Sale | 18,385 | 2.02 | 37,119 |
| 2016-04-22 | Memorial Sloan-kettering Cancer Center | Sale | 27,692 | 2.08 | 57,460 |
| 2016-04-21 | Memorial Sloan-kettering Cancer Center | Sale | 13,000 | 2.04 | 26,585 |
| 2016-04-20 | Memorial Sloan-kettering Cancer Center | Sale | 33,497 | 2.02 | 67,663 |
| 2016-04-19 | Memorial Sloan-kettering Cancer Center | Sale | 150,000 | 2.04 | 305,250 |
| 2016-04-18 | Seth Sandesh | Buy | 6,500 | 1.99 | 12,902 |
| 2016-04-15 | Seth Sandesh | Buy | 3,500 | 2.00 | 7,017 |
| 2016-04-15 | Traversa Sergio | Buy | 1,000 | 2.02 | 2,020 |
| 2016-04-14 | Nicholson, C. David | Buy | 5,000 | 2.00 | 10,000 |
| 2016-04-14 | Seth Sandesh | Buy | 5,000 | 2.00 | 10,000 |
| 2016-04-14 | Traversa Sergio | Buy | 2,000 | 2.02 | 4,040 |
| 2016-04-14 | Dave Kaushik J (CEO and Interim CFO) | Buy | 10,000 | 2.02 | 20,150 |
| 2016-04-14 | Steinhart Richard I | Buy | 2,500 | 2.01 | 5,024 |
Insider trading activities including stock purchases, stock sales, and option exercises of ATNM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Actinium Pharmaceuticals, Inc. (symbol ATNM, CIK number 1388320) see the Securities and Exchange Commission (SEC) website.